Glatiramer Acetate – Risk of anaphylactic reactions
14/08/2024
Medicines for human use
Direct healthcare professional communication (DHPC)
Important Safety Information from Teva Pharmaceuticals Ireland and Viatris Limited regarding Glatiramer acetate: Anaphylactic reactions may occur months up to years after treatment initiation